PWAM
CLBT icon

Park West Asset Management’s Cellebrite CLBT Stock Holding History

Park West Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,750,000
Closed -$25M – 151
2021
Q3 		$25M Buy
+2,750,000
New +$28.7M 0.59% 39

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return
IP
Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $40.5M AUM 5.55% 1-Year Est. Return
BCM
Bienville Capital Management New York $750M AUM 2.59% 1-Year Est. Return

Park West Asset Management's CLBT Position: Q4 2021 in Review

Park West Asset Management sold out of Cellebrite (CLBT) in Q4 2021, closing a stake of 2,750,000 shares — an estimated $25M sold.

Park West Asset Management first reported a position in CLBT in Q3 2021 and held it in 1 quarter. The position peaked at $25M in Q3 2021. 48 funds tracked by Wall St. Rank hold CLBT as of Q4 2021.

  • Park West Asset Management reported no remaining Cellebrite position as of Q4 2021 after selling out during the quarter.
  • Park West Asset Management sold 2,750,000 Cellebrite shares in Q4 2021, an estimated $25M.
  • Park West Asset Management first reported a position in Cellebrite in Q3 2021 and held it in 1 quarter.
  • Park West Asset Management's Cellebrite position peaked at $25M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Cellebrite as of Q4 2021.

Based on Park West Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.